What is the price of Lattice Biologics Ltd. (LBLTF)

The price of Lattice Biologics Ltd. (LBLTF) is $0.0001

What is the market cap of Lattice Biologics Ltd. (LBLTF)

The market cap of Lattice Biologics Ltd. (LBLTF) is $16.55K

Lattice Biologics Ltd. (LBLTF) Shares Outstanding

Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications. The company's innovative offerings include novel amniotic fluid-based therapies such as AmnioBoost and AmnioBlast. In addition, their product line features a broad range of allografts, encompassing traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix varieties. These versatile products serve numerous critical medical applications, from enhancing spinal fusion and aiding breast reconstruction post-mastectomy to promoting bone regeneration in foot and ankle surgeries and fostering skull healing after neurosurgery. They also play a role in improving wound repair for burn victims, facilitating hernia repair, addressing subchondral bone defects in knee and other joint surgeries, and supporting various sports medicine procedures, including anterior and posterior cruciate ligament repairs. The company's headquarters are located in Belgrade, Montana.

Year	Shares Outstanding	Change
Not enough data for the provided dates.

Year

Shares Outstanding

Change

Not enough data for the provided dates.

Company	Shares Outstanding	Difference	Country
Abbott Laboratories ABT.US	1.74B	-	US
Stryker Corporation SYK.US	383.50M	-	US
Medtronic plc MDT.US	1.28B	-	IE
Boston Scientific Corporation BSX.US	1.48B	-	US
Edwards Lifesciences Corporation EW.US	576.40M	-	US

Company

Shares Outstanding

Difference

Country